information, however, on patients' past exposures to animals and ectoparasites was not available.
In 1995, Drancourt and co-workers reported three cases of B. quintana endocarditis among HIV-negative, homeless, alcoholic men in France (8) . One of the patients had reported contact with a dog, and one had reported contact with dogs and cats; however, a current or past history of infection with lice or scabies was not documented for any of the patients. In 1995, Stein and Raoult also reported serologic evidence of B. quintana infection in an HIV-negative, homeless man from Marseilles, who had a relapsing febrile illness and a history of louse infestation (9) .
As a follow-up to the 1993 B. quintana outbreak in Seattle in 1994, we conducted a seroprevalence study of anti-Bartonella antibodies among patients at a community clinic in the "skid row" section of Seattle, which serves a primarily homeless and indigent population (10) . The median age of the 192 patients included in the study was 45 years, 156 (81%) of the 192 were male, and 126 (66%) were classified as homeless.B. quintana IgG titers ≥ 64 were detected by an indirect fluorescence antibody assay (11) in 39 (20%) of the 192 clinic patients. In contrast, only 4 (2%) of 199 banked blood specimens from an age-matched and sex-matched comparison group of Seattle volunteer blood donors had titers ≥ 64 (p < 0.001). Among clinic patients, seropositivity (titer ≥ 64) was associated by univariate analysis with older age, homelessness (relative risk [RR] 2.0; 95% confidence interval [CI] 1.0-4.1), alcohol abuse (RR, 2.5; 95% CI 1.4-4.2), smoking (RR, 2.0; 95% CI 1.2 -3.4), and injection drug use (RR, 2.5; 95% CI 1.3-4.8). By multivariate analysis, only alcohol abuse remained independently associated with seropositivity (odds ratio 3.3; 95% CI 1.6-6.9), and of 39 seropositive patients, 21 (54%) had a history of chronic alcoholism. Reliable data on past exposure to animals or ectoparasites were also not available for patients in this study.
The study was limited by the well-described cross-reactivity of the assay between Bartonella species (12, 13) , and most (62%) clinic patients with B. quintana titers ≥ 64 also had titers ≥ 64 to B. henselae. It is, therefore, possible that some of the seropositive patients may have been exposed
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to Bartonella species other than B. quintana. These findings do, however, show that a surprisingly high proportion of clinic patients without a history of documented Bartonella infection had detectable anti-Bartonella antibodies and may have been exposed to B. quintana.
Multiple factors, including those related to disease transmission, host susceptibility, and ability to detect the organism, have likely contributed to the emergence of B. quintana infection among the homeless. Transmission of B. quintana from human to human by the body louse, Pediculus humanus, has been experimentally documented (1) and is believed to have been the predominant mode of transmission of epidemic trench fever in World Wars I and II. Lice reside primarily in the seams of clothing and are easily killed by immersion in water 50°C or warmer (14) , which explains the propensity for louse-borne infections among displaced persons or wartime troops. Although these reports of B. quintana infection among homeless persons lack sufficient information to conclusively determine the disease vector, louseborne infection remains a plausible hypothesis. Lice, however, have not been associated with bacillary angiomatosis among AIDS patients, although exposure to cats (and, therefore, possibly to fleas) has been associated with bacillary angiomatosis and bacillary peliosis caused by Bartonella species (15) and with cat-scratch disease caused by B. henselae (16) . Thus, it is possible that B. quintana infection is spread among homeless persons by as yet unidentified vectors or reservoirs.
Homeless persons are also at risk for non-vectorborne infectious diseases. An increased risk for tuberculosis in this population is well documented (17, 18) , and outbreaks of meningococcal disease (19, 20) , pneumococcal disease (21), and diphtheria (22, 23) have been reported. It is likely that factors such as crowding, altered immunity due to alcoholism or other co-existing health problems, and inadequate or infrequent access to medical care affect the transmission and spread of infectious diseases among the homeless. Previous studies have shown that the clinical response to a standard inoculum of B. quintana varies substantially in experimental study patients (1); this variation indicates that host factors are likely important determinants of the risk for clinical infection following exposure to the organism.
Although cases of B. quintana bacteremia among homeless persons have thus far been reported only from France and Seattle, Washington, the problem is probably not confined to these locations. B. quintana is a fastidious and slow-growing bacterium that generally requires special culturing techniques for isolation (3) (4) (5) 24) , and many clinical laboratories do not routinely use blood culturing methods that are sensitive for isolating this organism. Moreover, B. quintana infection can result in a broad range of often nonspecific clinical manifestations (1, 3-5); therefore, case-patients evaluated for suspected bacteremia may represent only a small proportion of infected persons, as suggested by the results of the Seattle seroprevalence survey. To better define the geographic distribution and prevalence of B. quintana infection among homeless populations, a heightened awareness for this infection on the part of clinicians and the use of appropriate culture techniques by microbiology laboratories serving this population are needed. In addition, more specific serologic tests would aid in the diagnosis and assessment of the epidemiologic characteristics of B. quintana infections.
The optimal treatment regimen for HIV-negative patients with suspected or confirmed B. quintana infection has not been established. Minimal published data exist regarding antimicrobial therapy for this infection, and in vitro susceptibility testing has proven unreliable (25) . Nonetheless, on the basis of limited data, we believe it is reasonable to treat immunocompetent patients who have uncomplicated B. quintana bacteremia with at least 14 days of oral therapy with erythromycin, azithromycin, doxycycline, or tetracycline. In the 1993 Seattle outbreak, most patients had a satisfactory response to treatment with a beta-lactam agent followed by either erythromycin or azithromycin for 14 days (7). Although the number of patients identified with B. quintana endocarditis is small, most of these patients have required cardiac valve replacement despite intravenous antimicrobial therapy (5, 8, 26) . Therefore, we recommend that patients with B. quintana endocarditis receive a more prolonged course of at least 4 to 6 months of antimicrobial therapy and cardiac valve replacement if needed. Further study is needed to determine the role of bactericidal agents, such as third generation cephalosporins or quinolones, as monotherapy or in combination with a bacteriostatic agent for treating invasive B. quintana infections.
Many aspects of the acquisition and pathogenesis of B. quintana infections, and specifically B. quintana infections among the homeless, are not well defined. Changes in the organism itself that have led to increased virulence may in part account for its reemergence; however, microbiologic data that can support or refute this hypothesis are lacking (27) . The absence of recently identified cases in Seattle and in other areas with laboratories that use culture techniques appropriate for isolating Bartonella species suggests an episodic pattern of disease, with few or no cases occurring during interepidemic periods. It seems clear, however, that this most recent emergence of an old disease is related, at least in part, to societal factors that have contributed to urban decay and the existence of large homeless populations in our cities. As with other emerging infectious diseases, further efforts to identify, evaluate, and control B. quintana infections among homeless persons are challenges that will require the coordinated effort of clinicians, microbiologists, and public health officials.
